Immunoconjugates of myostatin for the treatment of muscle wasting

摘要

Immunological compositions and methods for reducing myostatin activity in vertebrate subjects are disclosed. The compositions include myostatin peptide immunogens, myostatin multimers and/or myostatin immunoconjugates capable of eliciting an immune response to a vertebrate subject to which the compositions are administered. The methods are useful for the treatment of a wide variety of disorders.